Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_assertion type Assertion NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_head.
- NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_assertion description "[While DNMT2 and DNMT3A expression appear to be normal, two- to fourfold increase in DNMT1 and DNMT3B were found in both Grade I and Grade III endometrioid cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_provenance.
- NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_assertion evidence source_evidence_literature NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_provenance.
- NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_assertion SIO_000772 15721400 NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_provenance.
- NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_assertion wasDerivedFrom befree-20140225 NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_provenance.
- NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_assertion wasGeneratedBy ECO_0000203 NP338994.RAr-VX-Q6PyprgMBbO9CLlaCg2qaxYcbDV6U3edeYB1fI130_provenance.